XC
Live / Allowed — Publication / registration review complete (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 May 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99829715
- Mark type
- Stylized text
- Filed
- 18 May 2026
- Published for opposition
- 29 Sept 2026
- Attorney of record
- Karen K. Won
Goods and services
- Class 040 — Treatment of materials: Custom bioengineering of human donor organs for transplantation to produce bioengineered whole organ grafts; Custom manufacturing of bioengineered human organ grafts for transplantation; Treatment and processing of biological materials, namely, extracorporeal rehabilitation of human donor organs and ex vivo perfusion of human donor organs for use in clinical organ transplantation
- Class 042 — Scientific and technological services: Medical scientific research and development services in the fields of regenerative medicine, bioengineering of human organs, bioreactor and perfusion technologies involving human organs, and technologies for extracorporeal organ support, reconditioning, and rehabilitation; Medical scientific research and development services, namely, cellular and molecular analysis of human organs, testing of pharmaceuticals on human organs, and development of chemical reagents and biochemical assays for human organs; Medical research laboratory services in the field of tissue engineering and organ bioengineering
Owner
- Xylyx Bio, Inc., Brooklyn, NY, US
Prosecution history
- 01 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Aug 2026 — ASSIGNED TO EXAMINER
- 31 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 May 2026 — APPLICATION FILING RECEIPT MAILED
- 18 May 2026 — NEW APPLICATION ENTERED